Login

Join Now

New BioUtah Member Benefit

Access Non-Dilutive Funding

BioUtah members can now access a monthly report detailing current non-dilutive government funding opportunities

Next Webinar: August 16 at 1 PM MT. Register today.

Register Access Report

The voice of utah’s life sciences community

As the association representing Utah’s burgeoning life sciences industry, BioUtah strives to develop an ecosystem in which Utah life sciences companies can succeed in developing and delivering technologies that save lives.

Learn More

Medical Device

Pharmaceuticals

Diagnostics / Laboratory

Biotechnology

Icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY

July 29, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
SkinTE® Met Primary and Secondary Endpoints in Final Analysis from Diabetic Foot Ulcer Trial

PolarityTE on July 28 announced final data from a multi-center randomized controlled trial evaluating treatment of Diabetic Foot Ulcers (DFU) with its investigational product SkinTE®. The trial met the primary endpoint of wound closure at 12 weeks and secondary endpoint of Percent Area Reduction (PAR) assessed at 4, 6, 8, 10, and 12 weeks. Nikolai […]

July 29, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
PolarityTE Receives Notice of Allowance for Chinese Patent

PolarityTE recently announced that the China National Intellectual Property Administration (CNIPA) issued a Notification of Allowance for Chinese Patent Application No. 201580075326.3. The allowed claims relate to skin-regenerative compositions utilizing PolarityTE’s minimally polarized functional unit (MPFU) technology as well as methods of making a skin-regenerative composition utilizing the MPFU technology. This most recent allowance further […]

July 29, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
PolarityTE Submits Investigational New Drug Application for SkinTE®

PolarityTE on Monday announced the submission of an investigational new drug application (IND) to the FDA seeking authorization to commence a clinical trial to evaluate its SkinTE product for the proposed indication of treatment of chronic cutaneous ulcers. SkinTE is PolarityTE’s human cellular and tissue-based product derived from a patient’s own skin. David Seaburg, Chief Executive […]

See More BioUtah News

From Here to There

See how BioUtah, the only trade association dedicated solely to Utah’s Life Sciences industry, can help your business grow.


Networking

Advocacy

Investment

Workforce Development

BioUtah is Powered by

Legacy Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors